Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (1910)	9/28/2007 12:38:52 PM
From: Jibacoa	Read Replies (2) \| Respond to of 3722

NASI Is up 17 % as it is trying to rally from the $0.50 level.<g> bigcharts.marketwatch.com It announced that its ClearPath-HDR device has been used in a patient for the first time.<g> ClearPath is implanted through a single incision and is designed to minimize radiation exposure of nearby healthy tissue.It offers targeted, effective radiation treatment as well as convenience and comfort.(It takes 5 days instead of 8 weeks for external beam radiation therapy.) ClearPath-HDR is designed to deliver the same positive results of the multiple-catheter approach, and it significantly reduce the patient discomfort associated with the other method. ClearPath can make APBI a possibility for more patients that were previously not considered good candidates for treatment with balloon brachytherapy products.Its is placed in the patient through a single incision and designed to adapt to the resection cavity. NASI has received 510k approval from the FDA for both ClearPath-HDR and ClearPath-CR.It estimates that the ClearPath systems will serve an addressable market of more than $500M The stock is selling around 0.8xBV.Doesn't have significant LTD. The insiders hold > 20% & institutions > 30% If the stock can get back to the $1 level it would be a nice % gain.<g> Today's volume is almost 5x its ADV. bigcharts.marketwatch.com The H in March 200 was 31.75 <g> bigcharts.marketwatch.com Bernard